- Dolutegravir-Based ART Recommended in Pregnancy, Postpartum Period
- Long-Term Antibiotic Exposure May Increase Lung Cancer Risk
- Nirmatrelvir-Ritonavir Effective for Outpatient Treatment of COVID-19
- Certain Factors Increase Risk for UTIs After Radical Hysterectomies
- Maintenance Therapy Improves Quality of Life in Recurrent Vulvovaginal Candidosis
- Clindamycin Plus Vancomycin Has Similar Mortality Rate vs Linezolid for NSTIs
- Oral Therapeutic Vowst Now Available to Prevent C difficile Infection
- Short-Term NO2, PM2.5 Exposure Linked to Increased COPD Exacerbations in Women
- Diabetes Risk Higher Following COVID-19 infection
- Oral Antiviral Therapy Uptake Low for HBV-Related Hepatocellular Carcinoma
- CDC Warns of Potentially Fatal Bacterial Illness on US Gulf Coast
- Sustained Smoking Cessation Tied to Improved Mental Health
Clinical Tools
Powered by
Powered by 
FDA Grants Full Approval to Paxlovid to Treat COVID-19
African Caribbean Ethnicity Linked to Sight-threatening Diabetic Retinopathy
Drug-Drug Interactions May Be Common With Ritonavir-Containing COVID-19 Therapy
Cancer Patients With Diabetes May Have Worse Outcomes on ICIs
Risk for COVID-19-Related Death Elevated in Rare Autoimmune Rheumatic Diseases
